Síndrome de Cushing iatrogénico por corticoides inhalados en paciente VIH
Cushing syndrome in a HIV patient using inhaled steroids: report of one case
Rev. méd. Chile; 144 (7), 2016
Publication year: 2016
We report a 41-year-old man with HIV and a chronic obstructive pulmonary disease, treated for seven months with Fluticasone/Salmeterol and antiretroviral therapy (Lamivudine, Tenofovir, Atazanavir and Ritonavir). While using these medications, the patients developed a Cushing syndrome in a period of five months. After performing laboratory and imaging tests, it was concluded that the most probable cause of the syndrome was the interaction of inhaled steroids with Ritonavir. After discontinuing these medications the syndrome reverted in a period of 8 months.
Broncodilatadores/efectos adversos, Síndrome de Cushing/inducido químicamente, Fluticasona/efectos adversos, Infecciones por VIH/tratamiento farmacológico, Inhibidores de la Proteasa del VIH/efectos adversos, Xinafoato de Salmeterol/efectos adversos, Broncodilatadores/uso terapéutico, Síndrome de Cushing/diagnóstico, Interacciones Farmacológicas, Fluticasona/uso terapéutico, Inhibidores de la Proteasa del VIH/uso terapéutico, Nebulizadores y Vaporizadores, Xinafoato de Salmeterol/uso terapéutico